GIS
40
-4
DNB
34
-2
C
67
-7
MU
64
-4
OMC
28
-5
WU
1
-9
EIX
34
-6
SLG
50
-3
CMI
39
-6
MHK
42
-7
LOW
42
-4
KLAC
72
-4
SLB
42
3
BLK
57
-4
WMB
58
-2
GE
62
-3
QRVO
57
-4
SHW
34
-21
SJM
2
-4
CCI
25
-5
GIS
40
-4
DNB
34
-2
C
67
-7
MU
64
-4
OMC
28
-5
WU
1
-9
EIX
34
-6
SLG
50
-3
CMI
39
-6
MHK
42
-7
LOW
42
-4
KLAC
72
-4
SLB
42
3
BLK
57
-4
WMB
58
-2
GE
62
-3
QRVO
57
-4
SHW
34
-21
SJM
2
-4
CCI
25
-5
Financhill
Back

Immunovant 10K Form

Sell
33

IMVT
Immunovant

Last Price:
$15.49
Seasonality Move:
21.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IMVT News And Ratings

See the #1 stock for the next 7 days that we like better than IMVT

IMVT Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-110.8M
Price / Cash Flow: 0
Annual Sales: $4.16
Price / Book: 3.78

Profitability

EPS (TTM): -2.74000
Net Income (TTM): $-413.8M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Immunovant Earnings Forecast

Key Immunovant Financial Ratios

  • Per Share Earnings over the last 6 years have been positive in 1 years.

Immunovant Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IMVT
CUSIP: 45258J
Website: immunovant.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IMVT Technical Analysis vs Fundamental Analysis

Sell
33
Immunovant (IMVT) is a Sell

Is Immunovant a Buy or a Sell?

  • Immunovant stock is rated a Sell
    The current Immunovant [IMVT] share price is $15.66. The Score for IMVT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.